

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.25923304 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.25923304 |
| 3 | protoporphyrinogen IX metabolic process (GO:0046501) | 7.15709766 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.88318693 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.88318693 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.49799488 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.04730570 |
| 8 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.99670315 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.91410402 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.81505635 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.81505635 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.81505635 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.76458363 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.75562772 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.61364078 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.48780659 |
| 17 | porphyrin-containing compound biosynthetic process (GO:0006779) | 5.46741368 |
| 18 | urea metabolic process (GO:0019627) | 5.37843225 |
| 19 | urea cycle (GO:0000050) | 5.37843225 |
| 20 | omega-hydroxylase P450 pathway (GO:0097267) | 5.35733577 |
| 21 | glyoxylate metabolic process (GO:0046487) | 5.31360879 |
| 22 | cysteine metabolic process (GO:0006534) | 5.23153418 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21421684 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.11759029 |
| 25 | porphyrin-containing compound metabolic process (GO:0006778) | 5.06936270 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.04436703 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.04380637 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.98852180 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 4.98718930 |
| 30 | protein carboxylation (GO:0018214) | 4.95675989 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.95675989 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.94761116 |
| 33 | bile acid metabolic process (GO:0008206) | 4.94257461 |
| 34 | tetrapyrrole biosynthetic process (GO:0033014) | 4.86618224 |
| 35 | hemoglobin metabolic process (GO:0020027) | 4.84521460 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.81640719 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.77192395 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.76874831 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.70881388 |
| 40 | regulation of complement activation (GO:0030449) | 4.70490954 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.59238945 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.57887205 |
| 43 | lysine catabolic process (GO:0006554) | 4.56916398 |
| 44 | lysine metabolic process (GO:0006553) | 4.56916398 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.55494205 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.49806974 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.49806974 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.49806974 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.49153567 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.47718247 |
| 51 | response to methylmercury (GO:0051597) | 4.46396212 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.40980616 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.40516292 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.40516292 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.40497679 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 4.38379087 |
| 57 | drug metabolic process (GO:0017144) | 4.34573307 |
| 58 | iron ion import (GO:0097286) | 4.31935673 |
| 59 | glutamate metabolic process (GO:0006536) | 4.31250980 |
| 60 | phospholipid efflux (GO:0033700) | 4.29810900 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.26866664 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 4.18846212 |
| 63 | negative regulation of sterol transport (GO:0032372) | 4.18846212 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.14737766 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 4.13753371 |
| 66 | ethanol metabolic process (GO:0006067) | 4.10308746 |
| 67 | oxidative demethylation (GO:0070989) | 4.10251514 |
| 68 | cholesterol efflux (GO:0033344) | 4.09926564 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09233012 |
| 70 | gas transport (GO:0015669) | 4.06399534 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 4.02032674 |
| 72 | glycine metabolic process (GO:0006544) | 3.98585669 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 3.97720039 |
| 74 | amine catabolic process (GO:0009310) | 3.97720039 |
| 75 | oxygen transport (GO:0015671) | 3.97035798 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 3.95018662 |
| 77 | cellular glucuronidation (GO:0052695) | 3.93879681 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.92381529 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.90746097 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.89670000 |
| 81 | ketone body metabolic process (GO:1902224) | 3.86249144 |
| 82 | drug catabolic process (GO:0042737) | 3.85823855 |
| 83 | heme metabolic process (GO:0042168) | 3.81869070 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.81779640 |
| 85 | heme biosynthetic process (GO:0006783) | 3.79149474 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 3.77985056 |
| 87 | response to mercury ion (GO:0046689) | 3.77054928 |
| 88 | ethanol oxidation (GO:0006069) | 3.76172999 |
| 89 | cofactor catabolic process (GO:0051187) | 3.72949730 |
| 90 | arginine metabolic process (GO:0006525) | 3.67777130 |
| 91 | positive regulation of lipid catabolic process (GO:0050996) | 3.65954505 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.65516778 |
| 93 | short-chain fatty acid metabolic process (GO:0046459) | 3.65508262 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 3.64602682 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.62361370 |
| 96 | carboxylic acid catabolic process (GO:0046395) | 3.61401384 |
| 97 | organic acid catabolic process (GO:0016054) | 3.61401384 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60541707 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 3.60092293 |
| 100 | fibrinolysis (GO:0042730) | 3.59957420 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 3.59702791 |
| 102 | S-adenosylmethionine metabolic process (GO:0046500) | 3.59039777 |
| 103 | aspartate family amino acid catabolic process (GO:0009068) | 3.55836221 |
| 104 | cytolysis (GO:0019835) | 3.54657861 |
| 105 | blood coagulation, intrinsic pathway (GO:0007597) | 3.53220587 |
| 106 | flavonoid metabolic process (GO:0009812) | 3.52057371 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51359050 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51359050 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.51089279 |
| 110 | complement activation, classical pathway (GO:0006958) | 3.50960579 |
| 111 | phenylpropanoid metabolic process (GO:0009698) | 3.50085614 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.49608523 |
| 113 | complement activation (GO:0006956) | 3.46895254 |
| 114 | uronic acid metabolic process (GO:0006063) | 3.45906433 |
| 115 | glucuronate metabolic process (GO:0019585) | 3.45906433 |
| 116 | sterol homeostasis (GO:0055092) | 3.44524875 |
| 117 | aldehyde catabolic process (GO:0046185) | 3.43596057 |
| 118 | protein activation cascade (GO:0072376) | 3.42983121 |
| 119 | plasma lipoprotein particle organization (GO:0071827) | 3.41509231 |
| 120 | exogenous drug catabolic process (GO:0042738) | 3.41431301 |
| 121 | negative regulation of protein activation cascade (GO:2000258) | 3.40548162 |
| 122 | tetrapyrrole metabolic process (GO:0033013) | 3.30223126 |
| 123 | heme transport (GO:0015886) | 3.27119489 |
| 124 | polyketide metabolic process (GO:0030638) | 3.21870503 |
| 125 | doxorubicin metabolic process (GO:0044598) | 3.21870503 |
| 126 | daunorubicin metabolic process (GO:0044597) | 3.21870503 |
| 127 | intestinal cholesterol absorption (GO:0030299) | 3.18587125 |
| 128 | protein-lipid complex assembly (GO:0065005) | 3.18287529 |
| 129 | positive regulation of hemostasis (GO:1900048) | 3.12354150 |
| 130 | positive regulation of blood coagulation (GO:0030194) | 3.12354150 |
| 131 | negative regulation of complement activation (GO:0045916) | 3.08466831 |
| 132 | response to lead ion (GO:0010288) | 3.02625911 |
| 133 | drug transmembrane transport (GO:0006855) | 3.00750077 |
| 134 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.98917591 |
| 135 | fructose metabolic process (GO:0006000) | 2.95851843 |
| 136 | oxaloacetate metabolic process (GO:0006107) | 2.95558547 |
| 137 | negative regulation of blood coagulation (GO:0030195) | 2.92138643 |
| 138 | negative regulation of hemostasis (GO:1900047) | 2.92138643 |
| 139 | creatine metabolic process (GO:0006600) | 2.91629663 |
| 140 | erythrocyte maturation (GO:0043249) | 2.89912856 |
| 141 | protein-lipid complex subunit organization (GO:0071825) | 2.87092095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.53111028 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.34108467 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.05490666 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.95082457 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.95918449 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.26308098 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.91081238 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.90387598 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.31014541 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.54105253 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.14369388 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01780093 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6456688 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90039665 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.76617163 |
| 16 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.73650853 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.71186198 |
| 18 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66823356 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65941759 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61330045 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57564514 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43176263 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39247124 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34234938 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33189776 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32773986 |
| 27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32622882 |
| 28 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32100124 |
| 29 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27975869 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22040319 |
| 31 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20846626 |
| 32 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.20696009 |
| 33 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19795738 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18327723 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17354242 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16187760 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.15583797 |
| 38 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15211984 |
| 39 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14160290 |
| 40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11636937 |
| 41 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11586212 |
| 42 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.08969174 |
| 43 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08030122 |
| 44 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08015861 |
| 45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06008760 |
| 46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05515045 |
| 47 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.05190847 |
| 48 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.04389511 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02223584 |
| 50 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01709109 |
| 51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01430066 |
| 52 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00149304 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99616860 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98338810 |
| 55 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.98140577 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97946927 |
| 57 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97285919 |
| 58 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.96898084 |
| 59 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.96051045 |
| 60 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.92533220 |
| 61 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92389094 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92285307 |
| 63 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.91965251 |
| 64 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91380786 |
| 65 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.90375195 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90261750 |
| 67 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89994166 |
| 68 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.88293806 |
| 69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87841181 |
| 70 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.87518547 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86937822 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86937822 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86568978 |
| 74 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.85873317 |
| 75 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.85670679 |
| 76 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85507963 |
| 77 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85441911 |
| 78 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.85343882 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85118253 |
| 80 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.84762580 |
| 81 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84473400 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83959828 |
| 83 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83444071 |
| 84 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.83411023 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83230130 |
| 86 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.82946792 |
| 87 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82801913 |
| 88 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.81985957 |
| 89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81866730 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81121231 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80907682 |
| 92 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.78372074 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78091336 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.77824993 |
| 95 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77610539 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76916169 |
| 97 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.76900308 |
| 98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.76753750 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73972826 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.73770820 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72633728 |
| 102 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.67232276 |
| 103 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.66675329 |
| 104 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65694705 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.64806470 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62654125 |
| 107 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62624594 |
| 108 | CBP_21632823_ChIP-Seq_H3396_Human | 0.62405252 |
| 109 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.61545282 |
| 110 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61452615 |
| 111 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.60673342 |
| 112 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.60018905 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59584041 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.58921969 |
| 115 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58702726 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58518378 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.58515944 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.57392448 |
| 119 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.57183800 |
| 120 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.56367023 |
| 121 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.56156290 |
| 122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.55509442 |
| 123 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.55250326 |
| 124 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.55195452 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.54548536 |
| 126 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54433837 |
| 127 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.52455035 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52226033 |
| 129 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.51914052 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.51057264 |
| 131 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.50905101 |
| 132 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.50900848 |
| 133 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.50608427 |
| 134 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.50265310 |
| 135 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.50074701 |
| 136 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49616638 |
| 137 | NCOR_22424771_ChIP-Seq_293T_Human | 0.49351874 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48775087 |
| 139 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48709197 |
| 140 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.48446679 |
| 141 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.47881352 |
| 142 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.47881352 |
| 143 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.47878706 |
| 144 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.47572922 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47348593 |
| 146 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.47280377 |
| 147 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.47267906 |
| 148 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.46906496 |
| 149 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46877493 |
| 150 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.46003398 |
| 151 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.45988502 |
| 152 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.45955141 |
| 153 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.45503503 |
| 154 | P300_19829295_ChIP-Seq_ESCs_Human | 0.45502377 |
| 155 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.45437125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.25417656 |
| 2 | MP0005360_urolithiasis | 7.02302815 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.39199415 |
| 4 | MP0005365_abnormal_bile_salt | 6.14063819 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.97166998 |
| 6 | MP0003252_abnormal_bile_duct | 3.90943950 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.88571052 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.52860921 |
| 9 | MP0005083_abnormal_biliary_tract | 3.23069805 |
| 10 | MP0009840_abnormal_foam_cell | 2.93185813 |
| 11 | MP0003195_calcinosis | 2.87436820 |
| 12 | MP0005332_abnormal_amino_acid | 2.66655504 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59324631 |
| 14 | MP0002118_abnormal_lipid_homeostasis | 2.15320895 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.07424321 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.05552788 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.04841014 |
| 18 | MP0003868_abnormal_feces_composition | 2.03869096 |
| 19 | MP0000609_abnormal_liver_physiology | 2.03726393 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 1.84727499 |
| 21 | MP0004215_abnormal_myocardial_fiber | 1.71576047 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.70433810 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.69213170 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.68138636 |
| 25 | MP0000749_muscle_degeneration | 1.60912370 |
| 26 | MP0008775_abnormal_heart_ventricle | 1.59244422 |
| 27 | MP0001764_abnormal_homeostasis | 1.59081038 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53466632 |
| 29 | MP0003011_delayed_dark_adaptation | 1.48148563 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.45405819 |
| 31 | MP0009697_abnormal_copulation | 1.40219874 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.38624973 |
| 33 | MP0005451_abnormal_body_composition | 1.26710479 |
| 34 | MP0000604_amyloidosis | 1.25418096 |
| 35 | MP0003329_amyloid_beta_deposits | 1.15019638 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.11442331 |
| 37 | MP0005647_abnormal_sex_gland | 1.09281172 |
| 38 | MP0008995_early_reproductive_senescence | 1.08521903 |
| 39 | MP0008057_abnormal_DNA_replication | 1.06202404 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 1.05915133 |
| 41 | MP0003646_muscle_fatigue | 1.05417751 |
| 42 | MP0004484_altered_response_of | 1.05095520 |
| 43 | MP0002972_abnormal_cardiac_muscle | 1.02436197 |
| 44 | MP0005330_cardiomyopathy | 1.01694371 |
| 45 | MP0000598_abnormal_liver_morphology | 1.00042830 |
| 46 | MP0002876_abnormal_thyroid_physiology | 0.98258489 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.96231325 |
| 48 | MP0002254_reproductive_system_inflammat | 0.95918757 |
| 49 | MP0003186_abnormal_redox_activity | 0.95683739 |
| 50 | MP0005535_abnormal_body_temperature | 0.95648129 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 0.93053195 |
| 52 | MP0005620_abnormal_muscle_contractility | 0.88979529 |
| 53 | MP0006138_congestive_heart_failure | 0.87503268 |
| 54 | MP0000747_muscle_weakness | 0.86743711 |
| 55 | MP0002822_catalepsy | 0.86250149 |
| 56 | MP0004130_abnormal_muscle_cell | 0.86203497 |
| 57 | MP0009764_decreased_sensitivity_to | 0.85652064 |
| 58 | MP0000462_abnormal_digestive_system | 0.84064048 |
| 59 | MP0009642_abnormal_blood_homeostasis | 0.81893963 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 0.81485988 |
| 61 | MP0002332_abnormal_exercise_endurance | 0.81096947 |
| 62 | MP0003690_abnormal_glial_cell | 0.80798921 |
| 63 | MP0004087_abnormal_muscle_fiber | 0.79995744 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 0.79971542 |
| 65 | MP0003950_abnormal_plasma_membrane | 0.79565900 |
| 66 | MP0005408_hypopigmentation | 0.79394463 |
| 67 | MP0000751_myopathy | 0.78990483 |
| 68 | MP0009763_increased_sensitivity_to | 0.77179211 |
| 69 | MP0004147_increased_porphyrin_level | 0.76758007 |
| 70 | MP0005385_cardiovascular_system_phenoty | 0.74907682 |
| 71 | MP0001544_abnormal_cardiovascular_syste | 0.74907682 |
| 72 | MP0005376_homeostasis/metabolism_phenot | 0.73740489 |
| 73 | MP0002971_abnormal_brown_adipose | 0.72196478 |
| 74 | MP0006035_abnormal_mitochondrial_morpho | 0.72068813 |
| 75 | MP0004085_abnormal_heartbeat | 0.71498487 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.71217659 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.70930466 |
| 78 | MP0005334_abnormal_fat_pad | 0.70842779 |
| 79 | MP0000639_abnormal_adrenal_gland | 0.70386394 |
| 80 | MP0002009_preneoplasia | 0.69586079 |
| 81 | MP0004043_abnormal_pH_regulation | 0.68713168 |
| 82 | MP0001661_extended_life_span | 0.67529821 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.67497067 |
| 84 | MP0005448_abnormal_energy_balance | 0.65197001 |
| 85 | MP0008469_abnormal_protein_level | 0.64791139 |
| 86 | MP0008260_abnormal_autophagy | 0.63531673 |
| 87 | MP0010630_abnormal_cardiac_muscle | 0.62528408 |
| 88 | MP0005670_abnormal_white_adipose | 0.62225560 |
| 89 | MP0004924_abnormal_behavior | 0.61997755 |
| 90 | MP0005386_behavior/neurological_phenoty | 0.61997755 |
| 91 | MP0008874_decreased_physiological_sensi | 0.60405141 |
| 92 | MP0008872_abnormal_physiological_respon | 0.60217462 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.59261552 |
| 94 | MP0005266_abnormal_metabolism | 0.58954837 |
| 95 | MP0001756_abnormal_urination | 0.58859518 |
| 96 | MP0001529_abnormal_vocalization | 0.57644211 |
| 97 | MP0002106_abnormal_muscle_physiology | 0.57614230 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 0.55835028 |
| 99 | MP0003953_abnormal_hormone_level | 0.54892934 |
| 100 | MP0003632_abnormal_nervous_system | 0.51149569 |
| 101 | MP0001664_abnormal_digestion | 0.50659853 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.49936707 |
| 103 | MP0002928_abnormal_bile_duct | 0.48024815 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.47947335 |
| 105 | MP0000579_abnormal_nail_morphology | 0.46975728 |
| 106 | MP0004270_analgesia | 0.45285531 |
| 107 | MP0003633_abnormal_nervous_system | 0.45272829 |
| 108 | MP0003638_abnormal_response/metabolism_ | 0.43837837 |
| 109 | MP0003075_altered_response_to | 0.43790437 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.43124317 |
| 111 | MP0001765_abnormal_ion_homeostasis | 0.39776661 |
| 112 | MP0002090_abnormal_vision | 0.39492853 |
| 113 | MP0010234_abnormal_vibrissa_follicle | 0.38757764 |
| 114 | MP0005395_other_phenotype | 0.37726989 |
| 115 | MP0001944_abnormal_pancreas_morphology | 0.36910833 |
| 116 | MP0005646_abnormal_pituitary_gland | 0.36896246 |
| 117 | MP0005248_abnormal_Harderian_gland | 0.36383589 |
| 118 | MP0005166_decreased_susceptibility_to | 0.35168694 |
| 119 | MP0003631_nervous_system_phenotype | 0.34938836 |
| 120 | MP0002796_impaired_skin_barrier | 0.34438675 |
| 121 | MP0000427_abnormal_hair_cycle | 0.33635464 |
| 122 | MP0002069_abnormal_eating/drinking_beha | 0.33620722 |
| 123 | MP0003879_abnormal_hair_cell | 0.33438958 |
| 124 | MP0003718_maternal_effect | 0.33117632 |
| 125 | MP0009745_abnormal_behavioral_response | 0.32314768 |
| 126 | MP0004381_abnormal_hair_follicle | 0.32097140 |
| 127 | MP0008873_increased_physiological_sensi | 0.31325535 |
| 128 | MP0004142_abnormal_muscle_tone | 0.30875818 |
| 129 | MP0002269_muscular_atrophy | 0.30728496 |
| 130 | MP0005187_abnormal_penis_morphology | 0.29967935 |
| 131 | MP0009672_abnormal_birth_weight | 0.29954419 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.29555200 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.29151842 |
| 134 | MP0002064_seizures | 0.29127817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.11725926 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.02345029 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.90737625 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.31310165 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.21271075 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.19528175 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.19095881 |
| 8 | Xanthomatosis (HP:0000991) | 6.07362501 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.31244392 |
| 10 | Complement deficiency (HP:0004431) | 5.08076844 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.61186609 |
| 12 | Epidermoid cyst (HP:0200040) | 4.52200713 |
| 13 | Hyperglycinemia (HP:0002154) | 4.43404074 |
| 14 | Hyperammonemia (HP:0001987) | 4.33704650 |
| 15 | Ketosis (HP:0001946) | 4.28660634 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.26644185 |
| 17 | Joint hemorrhage (HP:0005261) | 4.23593492 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19834146 |
| 19 | Osteomalacia (HP:0002749) | 4.13545290 |
| 20 | Fat malabsorption (HP:0002630) | 4.06912105 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.99851609 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.95182679 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.91400839 |
| 24 | Conjugated hyperbilirubinemia (HP:0002908) | 3.86604351 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.84008206 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.83519290 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.77731791 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.77731791 |
| 29 | Hyperglycinuria (HP:0003108) | 3.73690772 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71355491 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.70066896 |
| 32 | Abnormality of complement system (HP:0005339) | 3.56229361 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.45358361 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.40989751 |
| 35 | Polycythemia (HP:0001901) | 3.39759792 |
| 36 | Ketoacidosis (HP:0001993) | 3.25368788 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17157477 |
| 38 | Acanthocytosis (HP:0001927) | 3.15947258 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.14417501 |
| 40 | Paralysis (HP:0003470) | 3.07237477 |
| 41 | Abnormality of reticulocytes (HP:0004312) | 3.06270890 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 3.01676373 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01646008 |
| 44 | Steatorrhea (HP:0002570) | 2.94969001 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 2.94651147 |
| 46 | Spontaneous abortion (HP:0005268) | 2.93250312 |
| 47 | Abnormal hemoglobin (HP:0011902) | 2.91633308 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.91573668 |
| 49 | Diaphragmatic weakness (HP:0009113) | 2.90894080 |
| 50 | Gout (HP:0001997) | 2.88600926 |
| 51 | Skin nodule (HP:0200036) | 2.87913861 |
| 52 | Abnormal gallbladder morphology (HP:0012437) | 2.83240594 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.83008124 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.82776185 |
| 55 | Abnormal gallbladder physiology (HP:0012438) | 2.76949409 |
| 56 | Cholecystitis (HP:0001082) | 2.76949409 |
| 57 | Cholelithiasis (HP:0001081) | 2.74363841 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.73971239 |
| 59 | Bundle branch block (HP:0011710) | 2.73487012 |
| 60 | Metabolic acidosis (HP:0001942) | 2.70421686 |
| 61 | Abnormality of purine metabolism (HP:0004352) | 2.67303435 |
| 62 | Microcytic anemia (HP:0001935) | 2.64866834 |
| 63 | Ileus (HP:0002595) | 2.55970561 |
| 64 | Toxemia of pregnancy (HP:0100603) | 2.53744410 |
| 65 | Lethargy (HP:0001254) | 2.52203228 |
| 66 | Poikilocytosis (HP:0004447) | 2.48985547 |
| 67 | Sudden death (HP:0001699) | 2.45224771 |
| 68 | Myocardial infarction (HP:0001658) | 2.45156379 |
| 69 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.42930366 |
| 70 | Irritability (HP:0000737) | 2.40285941 |
| 71 | Neonatal onset (HP:0003623) | 2.36001022 |
| 72 | Cerebral edema (HP:0002181) | 2.34994341 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.33796157 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33796157 |
| 75 | Sensorimotor neuropathy (HP:0007141) | 2.31920537 |
| 76 | Vascular calcification (HP:0004934) | 2.26450755 |
| 77 | Brushfield spots (HP:0001088) | 2.25287321 |
| 78 | Ventricular fibrillation (HP:0001663) | 2.24698089 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.24600580 |
| 80 | Spastic diplegia (HP:0001264) | 2.24145328 |
| 81 | Abnormality of the gallbladder (HP:0005264) | 2.23381919 |
| 82 | Status epilepticus (HP:0002133) | 2.21314554 |
| 83 | Generalized hypopigmentation of hair (HP:0011358) | 2.17490863 |
| 84 | Late onset (HP:0003584) | 2.16794341 |
| 85 | Malnutrition (HP:0004395) | 2.15277991 |
| 86 | Mitral stenosis (HP:0001718) | 2.14601914 |
| 87 | Amyloidosis (HP:0011034) | 2.10830804 |
| 88 | Heart block (HP:0012722) | 2.10718960 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 2.10646222 |
| 90 | Fair hair (HP:0002286) | 2.07707412 |
| 91 | Cerebral palsy (HP:0100021) | 2.06793109 |
| 92 | Glomerulonephritis (HP:0000099) | 2.05765032 |
| 93 | Syncope (HP:0001279) | 2.05001936 |
| 94 | Exercise-induced myalgia (HP:0003738) | 2.04575324 |
| 95 | Atrioventricular block (HP:0001678) | 2.04566242 |
| 96 | Hyporeflexia of lower limbs (HP:0002600) | 2.02983087 |
| 97 | Enlarged kidneys (HP:0000105) | 2.01159544 |
| 98 | Hyperglycemia (HP:0003074) | 2.00815387 |
| 99 | Hyperventilation (HP:0002883) | 1.99166738 |
| 100 | Vomiting (HP:0002013) | 1.99054918 |
| 101 | Hypochromic anemia (HP:0001931) | 1.97876974 |
| 102 | Muscle fiber inclusion bodies (HP:0100299) | 1.97846750 |
| 103 | Cardiovascular calcification (HP:0011915) | 1.96000041 |
| 104 | Glycosuria (HP:0003076) | 1.95844791 |
| 105 | Abnormality of urine glucose concentration (HP:0011016) | 1.95844791 |
| 106 | Reticulocytosis (HP:0001923) | 1.95134247 |
| 107 | Pancreatitis (HP:0001733) | 1.94873397 |
| 108 | Abnormal atrioventricular conduction (HP:0005150) | 1.92827137 |
| 109 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.91442935 |
| 110 | Subaortic stenosis (HP:0001682) | 1.91442935 |
| 111 | Right ventricular cardiomyopathy (HP:0011663) | 1.89849388 |
| 112 | Increased mean platelet volume (HP:0011877) | 1.88187703 |
| 113 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.87609622 |
| 114 | Rickets (HP:0002748) | 1.87508553 |
| 115 | Ventricular arrhythmia (HP:0004308) | 1.87238423 |
| 116 | Nemaline bodies (HP:0003798) | 1.87162696 |
| 117 | Symptomatic seizures (HP:0011145) | 1.85856554 |
| 118 | Menorrhagia (HP:0000132) | 1.85444963 |
| 119 | Confusion (HP:0001289) | 1.85233726 |
| 120 | Nausea (HP:0002018) | 1.84579252 |
| 121 | Increased purine levels (HP:0004368) | 1.82800308 |
| 122 | Hyperuricemia (HP:0002149) | 1.82800308 |
| 123 | EMG: myopathic abnormalities (HP:0003458) | 1.82164709 |
| 124 | Alkalosis (HP:0001948) | 1.79683930 |
| 125 | Postural instability (HP:0002172) | 1.79608863 |
| 126 | Esophageal varix (HP:0002040) | 1.78890032 |
| 127 | Calf muscle hypertrophy (HP:0008981) | 1.78288401 |
| 128 | Generalized aminoaciduria (HP:0002909) | 1.77882430 |
| 129 | Opisthotonus (HP:0002179) | 1.77252851 |
| 130 | Tetraplegia (HP:0002445) | 1.76924033 |
| 131 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.76304015 |
| 132 | Gingival bleeding (HP:0000225) | 1.75887145 |
| 133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75733889 |
| 134 | Hemorrhage of the eye (HP:0011885) | 1.75370784 |
| 135 | Acute hepatic failure (HP:0006554) | 1.74911557 |
| 136 | Nephritis (HP:0000123) | 1.74900136 |
| 137 | Palpitations (HP:0001962) | 1.74007040 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73472108 |
| 139 | Arthropathy (HP:0003040) | 1.73048872 |
| 140 | Abnormality of vitamin metabolism (HP:0100508) | 1.71813128 |
| 141 | Thrombophlebitis (HP:0004418) | 1.71272243 |
| 142 | Death in childhood (HP:0003819) | 1.70907448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.72222093 |
| 2 | EIF2AK1 | 4.68097611 |
| 3 | OBSCN | 4.08485929 |
| 4 | SIK1 | 3.60019276 |
| 5 | INSRR | 3.44778361 |
| 6 | MAP2K4 | 3.34297340 |
| 7 | FGFR4 | 3.12712422 |
| 8 | DAPK2 | 2.82359114 |
| 9 | TAOK3 | 2.81854626 |
| 10 | ERN1 | 2.75858935 |
| 11 | ERBB4 | 2.60202103 |
| 12 | SCYL2 | 2.38586054 |
| 13 | PRPF4B | 2.33667747 |
| 14 | EPHA4 | 2.18002204 |
| 15 | TAF1 | 2.16223332 |
| 16 | FRK | 2.01769354 |
| 17 | STK24 | 1.93127219 |
| 18 | STK4 | 1.93021873 |
| 19 | MST1R | 1.92864603 |
| 20 | PINK1 | 1.80449651 |
| 21 | MAP3K4 | 1.79431552 |
| 22 | PIK3CG | 1.78848391 |
| 23 | PIK3CA | 1.75586800 |
| 24 | TRPM7 | 1.64794849 |
| 25 | FGFR2 | 1.58590111 |
| 26 | WNK1 | 1.57753369 |
| 27 | MAPK11 | 1.54053755 |
| 28 | BRSK2 | 1.49573342 |
| 29 | STK3 | 1.42549641 |
| 30 | LATS1 | 1.40726843 |
| 31 | NTRK3 | 1.37826985 |
| 32 | TTN | 1.29070739 |
| 33 | AKT3 | 1.24208687 |
| 34 | PDK4 | 1.24066058 |
| 35 | PDK3 | 1.24066058 |
| 36 | SGK2 | 1.22962072 |
| 37 | MAP2K7 | 1.19797324 |
| 38 | KSR1 | 1.18221505 |
| 39 | SGK3 | 1.17944417 |
| 40 | NTRK1 | 1.17898261 |
| 41 | MAP3K7 | 1.15707573 |
| 42 | SGK223 | 1.15366231 |
| 43 | SGK494 | 1.15366231 |
| 44 | JAK2 | 1.14169264 |
| 45 | MAP3K2 | 1.13689023 |
| 46 | ABL2 | 1.10008426 |
| 47 | SGK1 | 1.08768118 |
| 48 | PRKCG | 1.07974906 |
| 49 | PKN2 | 1.06622620 |
| 50 | TRIB3 | 1.04721928 |
| 51 | CAMKK1 | 1.04548029 |
| 52 | CASK | 1.03417155 |
| 53 | PRKAA2 | 1.02327107 |
| 54 | KSR2 | 1.02038821 |
| 55 | ACVR1B | 1.00386582 |
| 56 | MAP3K12 | 0.99080098 |
| 57 | CAMK2G | 0.99037569 |
| 58 | EEF2K | 0.98914019 |
| 59 | FLT3 | 0.98091831 |
| 60 | PLK2 | 0.97454875 |
| 61 | PRKCZ | 0.96448918 |
| 62 | PDPK1 | 0.95650258 |
| 63 | MAP3K9 | 0.95280065 |
| 64 | NEK9 | 0.94984361 |
| 65 | RET | 0.90145971 |
| 66 | ICK | 0.88578978 |
| 67 | ERBB2 | 0.88400808 |
| 68 | MYLK | 0.88320419 |
| 69 | PRKAA1 | 0.88243744 |
| 70 | PTK6 | 0.87072152 |
| 71 | MAPK12 | 0.85695845 |
| 72 | BMX | 0.84917951 |
| 73 | MAP3K1 | 0.84701660 |
| 74 | MET | 0.83673204 |
| 75 | PIM1 | 0.83540276 |
| 76 | PRKACG | 0.83401367 |
| 77 | MINK1 | 0.83382876 |
| 78 | DMPK | 0.83320791 |
| 79 | BRSK1 | 0.81564463 |
| 80 | PRKCI | 0.80683466 |
| 81 | PBK | 0.79754494 |
| 82 | STK11 | 0.79248301 |
| 83 | PDK1 | 0.76335700 |
| 84 | MAP2K3 | 0.75851024 |
| 85 | RAF1 | 0.75291788 |
| 86 | RPS6KA5 | 0.74011687 |
| 87 | MAPK4 | 0.73624496 |
| 88 | CLK1 | 0.73261753 |
| 89 | PLK3 | 0.72704696 |
| 90 | TAOK2 | 0.70965431 |
| 91 | MST4 | 0.70671090 |
| 92 | JAK1 | 0.69598366 |
| 93 | AKT2 | 0.69435957 |
| 94 | STK38 | 0.68592083 |
| 95 | CAMKK2 | 0.67805919 |
| 96 | MAPK15 | 0.67761111 |
| 97 | MAP2K1 | 0.66185259 |
| 98 | RIPK1 | 0.63770320 |
| 99 | TYK2 | 0.63483800 |
| 100 | PAK6 | 0.63171465 |
| 101 | CSNK1G2 | 0.62346043 |
| 102 | NEK1 | 0.61670626 |
| 103 | BRAF | 0.61643264 |
| 104 | STK39 | 0.61087572 |
| 105 | GRK5 | 0.60833617 |
| 106 | ZAK | 0.60670706 |
| 107 | DAPK1 | 0.59930989 |
| 108 | BMPR2 | 0.59570395 |
| 109 | CAMK2D | 0.57953883 |
| 110 | PTK2B | 0.54206205 |
| 111 | PAK3 | 0.53790489 |
| 112 | LATS2 | 0.53007065 |
| 113 | MAP2K6 | 0.52865979 |
| 114 | OXSR1 | 0.52834717 |
| 115 | CAMK1G | 0.52723010 |
| 116 | CAMK1 | 0.52511633 |
| 117 | MAPKAPK3 | 0.52106078 |
| 118 | PDK2 | 0.51984094 |
| 119 | GSK3A | 0.51483929 |
| 120 | STK38L | 0.51481377 |
| 121 | GRK6 | 0.50587164 |
| 122 | CAMK1D | 0.50402254 |
| 123 | CAMK2B | 0.50273313 |
| 124 | TTK | 0.47566694 |
| 125 | CAMK2A | 0.47060266 |
| 126 | PTK2 | 0.46998500 |
| 127 | MAPK7 | 0.46661320 |
| 128 | PRKCH | 0.44843662 |
| 129 | LMTK2 | 0.44730177 |
| 130 | MAP3K6 | 0.44655840 |
| 131 | MAP3K13 | 0.43437630 |
| 132 | PHKG2 | 0.41745943 |
| 133 | PHKG1 | 0.41745943 |
| 134 | RPS6KA3 | 0.41591818 |
| 135 | CSNK1G1 | 0.41293899 |
| 136 | MAP3K11 | 0.41229413 |
| 137 | DYRK1A | 0.40987049 |
| 138 | MAP3K5 | 0.40818170 |
| 139 | PRKCQ | 0.40491010 |
| 140 | PRKCA | 0.38966027 |
| 141 | FER | 0.38913036 |
| 142 | CAMK4 | 0.36942073 |
| 143 | PRKACA | 0.36026928 |
| 144 | DYRK1B | 0.35432106 |
| 145 | EPHA3 | 0.35222203 |
| 146 | PKN1 | 0.35057830 |
| 147 | CDK5 | 0.34813485 |
| 148 | EPHB1 | 0.34697334 |
| 149 | FGFR3 | 0.33533330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41585278 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.98984575 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38182426 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12701091 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04049571 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75004405 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59492837 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58293107 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53470622 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46229227 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40822091 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31620914 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24094677 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.01878126 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.01712127 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97213808 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95707212 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.87786560 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85728372 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84218864 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81174137 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.76748150 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75244764 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73454073 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68663114 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.63339502 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59363085 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56732699 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55979412 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54863384 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53623666 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49625774 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46140688 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43912804 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43457035 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41868209 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40727632 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40123602 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38691606 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37007887 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28520731 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.27873163 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26229550 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24932300 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21973616 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19446566 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16831069 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16560491 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13146173 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09660094 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08566606 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03985496 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93362637 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87466201 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85463851 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84396559 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75455765 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75169365 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74756385 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70178992 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70043951 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69740661 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.67119676 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63810319 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.61439416 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50041922 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49754821 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49639667 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44134530 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.39647826 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37070547 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36074653 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31797600 |
| 74 | Long-term potentiation_Homo sapiens_hsa04720 | 0.31351818 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30675688 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.29361176 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28909093 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28562034 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26661547 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25534488 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24723066 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22202575 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21841991 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20489000 |
| 85 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.20444469 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19109889 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18458759 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.17368613 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.14754754 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.13901962 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.12477929 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11022140 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09339352 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.07456518 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07175352 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.04542537 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02847110 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01898322 |
| 99 | Amphetamine addiction_Homo sapiens_hsa05031 | -0.1376772 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1326225 |
| 101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | -0.1278029 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1254287 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1081778 |
| 104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1076399 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1034017 |
| 106 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0853807 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0810177 |
| 108 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0807421 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0682746 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0482517 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0280025 |
| 112 | Insulin secretion_Homo sapiens_hsa04911 | -0.0125793 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0070329 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0060938 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0036052 |

